









Markets
/
Stocks
/
nasdaq-spro
/

Spero Therapeutics Inc

SPRO

View Detailed Chart

2.500USD

+0.370+17.37%

Close 05/30, 16:00（ET）Quotes delayed by 15 min

139.75MMarket Cap

LossP/E TTM



Spero Therapeutics Inc

2.500

+0.370+17.37%

Company

Intraday

30m

Today

+17.37%

5 Days

+259.04%

1 Month

+279.94%

6 Months

+119.30%

Year to Date

+142.72%

1 Year

+76.06%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

HOLD

Current Rating

5.000

Target Price

134.74%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

557

Total

Median

Average

Company name

Ratings

Analysts

Spero Therapeutics Inc

SPRO

Exact Sciences Corp

EXAS

CRISPR Therapeutics AG

CRSP

Regeneron Pharmaceuticals Inc

REGN

Intellia Therapeutics Inc

NTLA

IQVIA Holdings Inc

IQV

...

112

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(0)

Neutral(0)

Buy(9)

Indicators

Sell(0)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.320

Buy

RSI(14)

83.412

Overbought

STOCH(KDJ)(9,3,3)

82.054

Overbought

ATR(14)

0.190

High Vlolatility

CCI(14)

230.099

Overbought

Williams %R

18.325

Overbought

TRIX(12,20)

2.240

Buy

StochRSI(14)

75.398

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

1.311

Buy

MA10

0.991

Buy

MA20

0.807

Buy

MA50

0.752

Buy

MA100

0.799

Buy

MA200

1.016

Buy

News

More news coming soon, stay tuned...

Company

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Company codeSPRO

CompanySpero Therapeutics Inc

CEOMs. Esther Rajavelu

Websitehttps://sperotherapeutics.com/